REGN
RegeneronยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
REGN Profile
Regeneron Pharmaceuticals, Inc.
A company that developing drugs to treat eye diseases, inflammatory diseases and cancer
777 Old Saw Mill River Road, Tarrytown, NewYork 10591-6707
Production and sales of pharmaceutical products
Regeneron Pharmaceuticals, Inc. was founded in New York State in 1988. Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that discovers, invents, develops, manufactures and commercializes drugs for the treatment of serious diseases. Its commercialized drugs and product candidates under development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. Its core business strategy is to maintain a solid foundation in basic scientific research and discovery enabling technologies, and build on clinical development, manufacturing and commercial capabilities. Its goal is to continue to be a comprehensive, multi-product biotechnology company that provides patients and medical professionals with important options for the prevention and treatment of human diseases.
